Brief: Stevanato Group And Gerresheimer AG Announce Collaboration On The Development Of An Innovative Ready-To-Use Vial Platform For The Pharmaceutical Industry
07/09/2022 11:09
Sept 7 (Reuters) - Gerresheimer AG GXIG.DE :
* STEVANATO GROUP AND GERRESHEIMER AG ANNOUNCE COLLABORATION
ON
THE DEVELOPMENT OF AN INNOVATIVE READY-TO-USE VIAL PLATFORM FOR
THE PHARMACEUTICAL INDUSTRY
Source text for Eikon: ID:nBwbp0LW4a
Further company coverage: GXIG.DE
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Stevanato SpA
See all newsStevanato Group SpA reports results for the quarter ended June 30 - Earnings Summary
Corrected: BRIEF-Stevanato Q2 Net Income EUR 23 Million
SCHOTT Pharma jumps as DB ups to 'buy' on growth prospects
Italy's Stevanato Q1 revenue rises more than expected, helped by GLP-1 demand
Italy's Stevanato Q4 revenue beats on BDS unit strength